scispace - formally typeset
E

Elisenda Eixarch

Researcher at University of Barcelona

Publications -  188
Citations -  5280

Elisenda Eixarch is an academic researcher from University of Barcelona. The author has contributed to research in topics: Medicine & Gestational age. The author has an hindex of 32, co-authored 152 publications receiving 4297 citations. Previous affiliations of Elisenda Eixarch include Imperial College London & Hospital Sant Joan de Déu Barcelona.

Papers
More filters
Journal ArticleDOI

Fetoscopic laser surgery for twin-to-twin transfusion syndrome after 26 weeks of gestation.

TL;DR: Fetoscopic laser coagulation for TTTS performed between 26 + 0 and 28 + 6 weeks of gestation was associated with similar outcomes as those observed in cases treated before 26 weeks.
Journal ArticleDOI

Fully automatic 3D reconstruction of the placenta and its peripheral vasculature in intrauterine fetal MRI.

TL;DR: This work proposes a novel fully‐automated method to segment the placenta and its peripheral blood vessels from fetal MRI, and suggests that this methodology can aid the diagnosis and surgical planning of severe fetal disorders.
Journal ArticleDOI

Growth deficit in term small-for-gestational fetuses with normal umbilical artery Doppler is associated with adverse outcome.

TL;DR: In term growth restricted fetuses the degree of growth deficit from the optimal customized growth may be used to identify a subgroup of fetuses at high-risk for adverse outcomes.
Journal ArticleDOI

Micro-needle implantable electrochemical oxygen sensor: ex-vivo and in-vivo studies

TL;DR: The Pt-Nafion® sensor was characterized morphological and electrochemically showing a higher sensitivity than its bare counterpart, and was able to detect clear statistical differences of O2 between hyperoxia and hypoxia states in tissue.
Journal ArticleDOI

Cord occlusion followed by laser cord transection in monochorionic monoamniotic discordant twins

TL;DR: To compare the outcomes of a consecutive case series of monochorionic (MC) monoamniotic (MA) discordant twins treating with umbilical cord occlusion and transection, with those of a cohort of MC diamniotic (DA) twins treated with conventional cord occLusion.